共 197 条
[1]
Kuypers KPC(2019)Microdosing psychedelics: more questions than answers? An overview and suggestions for future research J Psychopharmacol 33 1039-1057
[2]
Ng L(2019)Psychedelic microdosing benefits and challenges: an empirical codebook Harm Reduct J 16 43-1197
[3]
Erritzoe D(2016)Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial J Psychopharmacol (Oxford) 30 1181-1461
[4]
Knudsen GM(2011)Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness J Psychopharmacol 25 1453-800
[5]
Nichols CD(2019)Acute subjective and behavioral effects of microdoses of lysergic acid diethylamide in healthy human volunteers Biol Psychiatry 86 792-1170
[6]
Nichols DE(2018)The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial Psychopharmacology. 236 1159-665
[7]
Pani L(2011)Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects Psychopharmacology. 218 649-12
[8]
Soula A(2021)Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing Sci Rep 11 1941-122
[9]
Nutt D(2019)Psychedelic microdosing: a subreddit analysis J Psychoactive Drugs 52 1-434
[10]
Anderson T(2019)Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube Harm Reduct J 16 63-120